Literature DB >> 21046185

A French approach to cost-effectiveness analysis?

Gérard de Pouvourville.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21046185     DOI: 10.1007/s10198-010-0284-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


× No keyword cloud information.
  3 in total

Review 1.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

2.  Is there a "continental" view of health economics evaluation?

Authors:  Claude Le Pen
Journal:  Eur J Health Econ       Date:  2009-05

3.  Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Authors:  Peter H Jones; Michael H Davidson; Evan A Stein; Harold E Bays; James M McKenney; Elinor Miller; Valerie A Cain; James W Blasetto
Journal:  Am J Cardiol       Date:  2003-07-15       Impact factor: 2.778

  3 in total
  4 in total

1.  Relative effectiveness and the European pharmaceutical market.

Authors:  Bengt Jönsson
Journal:  Eur J Health Econ       Date:  2011-04

2.  Does the approach to economic evaluation in health care depend on culture, values, and institutional context?

Authors:  Aleksandra Torbica; Rosanna Tarricone; Michael Drummond
Journal:  Eur J Health Econ       Date:  2018-07

3.  What values do the public want their health care systems to use in evaluating technologies?

Authors:  Martin J Buxton; James D Chambers
Journal:  Eur J Health Econ       Date:  2011-08

4.  A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environments.

Authors:  Marc Massetti; Samuel Aballéa; Yann Videau; Cécile Rémuzat; Julie Roïz; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2015-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.